article thumbnail

What You Need to Know About Cannabis and Coronavirus

NORML

NORML’s Responsible Consumer Safety Tips. Read and download NORML’s consumer safety tips. NORML wishes to reiterate its message that the public beware of online misinformation surrounding the use of either cannabis or CBD as a potential remedy for COVID-19. Download tips. Download memo.

Safety 344
article thumbnail

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The results renew calls from the hemp and CBD industries urging FDA to take steps to regulate CBD now, and calling on Congress to act if FDA continues to delay. The methods for both phases were the same.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.

Safety 52
article thumbnail

Consumer Brands Association Forms Expert Board to Provide Strategic Oversight of Advocacy Approach to CBD

Cannabis Law Report

Joining the CBD Advisory Board are: Mick Cornett, former Oklahoma City mayor; Edward Davis, former commissioner, Boston Police Department; Tom Galvin, executive director, Digital Citizens Alliance; Karen Tandy, former administrator, U.S. Food and Drug Administration’s enforcement and regulation of CBD in consumer products.

article thumbnail

FDA Hearing On ‘Hemp-Derived CBD’ Today

NORML

Washington, DC : Today the US Food and Drug Administration is taking in-person public testimony with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. ” Currently, commercially marketed CBD-infused products are not subject to explicit federal regulations. .”

Hemp 203
article thumbnail

Kentucky NORML Advocates for Medical Marijuana in Frankfort

NORML

Advocacy groups including Kentucky’s chapter of the National Organization for the Reform of Marijuana Laws (KY NORML), Kentuckians for Medical Marijuana (KY4MM) and Kentucky Cannabis Freedom Coalition (KCFC) organized advocacy day activities in Frankfort.

Advocacy 121
article thumbnail

NORML Issues Cannabis Policy Guidance For Lawmakers and Prosecutors For Protecting Public Health During COVID-19 Crisis

NORML

Today, NORML and it’s national network of advocacy chapters released a memo to state lawmakers, regulators, prosecutors, and other interested parties providing guidance for how they can take emergency actions to better promote the health and welfare of cannabis consumers and the general public during the COVID pandemic.

Policy 259